The Human Medicines Regulations 2012

[F1Packaging Requirements: medicinal products required to bear safety featuresU.K.
This section has no associated Explanatory Memorandum

257A.—(1) The information specified in paragraph 18A of Schedule 24 must not be removed or covered, either fully or partially, [F2from a product to which Article 54a of the 2001 Directive applies] unless the following conditions are met—

(a)a person who is the holder of a manufacturer’s licence verifies, prior to partially or fully removing or covering the features, that the medicinal product concerned is authentic and that it has not been tampered with;

(b)the holder of the manufacturer’s licence replaces the features with ones which are equivalent as regards the possibility to verify the authenticity, identification and to provide evidence of tampering of the medicinal product; and

(c)the replacement of the features is conducted in accordance with the applicable principles and guidelines for good manufacturing practice set out in the Good Manufacturing Practice Directive.

(2) For the purposes of paragraph (1)(b), the features shall be considered equivalent if they—

(a)comply with the requirements set out in Commission Regulation 2016/161; and

(b)are equally effective in enabling the verification of authenticity and identification of the medicinal product and in providing evidence of tampering with the medicinal product.

(3) In performing the activities referred to in paragraph (1), the holder of a manufacturer’s licence shall be regarded as a producer for the purposes of the Consumer Protection Act 1987.]

Textual Amendments

F1Regs. 257A, 257B inserted (9.2.2019) by The Human Medicines (Amendment) Regulations 2019 (S.I. 2019/62), regs. 1, 11 and regs. 257A, 257B inserted (N.I.) (9.2.2019) by The Human Medicines (Amendment) Regulations 2019 (S.R. 2019/10), regs. 1, 11